issues

Nanjing Jiangbei New Area Issues Global Call for Talents

NANJING, China, Sept. 20, 2025 /PRNewswire/ -- On September 20, Nobel laureates, academicians, young scientists, and emerging R&D professionals from…

4 months ago

Grvt Raises $19M to Pioneer Privacy-First Onchain Finance and Unlock Trillion-Dollar Markets

PANAMA CITY, Sept. 19, 2025 /PRNewswire/ -- Grvt, the preeminent DEX (decentralized exchange) for onchain financial privacy that is powered…

4 months ago

NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting

September 18, 2025 16:30 ET  | Source: NovaBay Pharmaceuticals Inc. EMERYVILLE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals,…

4 months ago

Public Interest Registry Welcomes Applications for its Advisory Council

RESTON, Va., Sept. 10, 2025 /PRNewswire/ -- Public Interest Registry (PIR) announced today that it is accepting applications for its…

5 months ago

Tecan issues CHF 150 million straight bond

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR…

6 months ago

WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules

WuXia293Stable platform demonstrates high titer, human glycosylation and improved product quality by eliminating or significantly alleviating truncation in difficult-to-express molecules.WuXia293Stable platform maintains…

6 months ago

Pheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading Rumors

BEIJING, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company,” “we,” “our” or “Pheton”), a healthcare solution…

6 months ago

Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge

ST. PAUL, Minn., July 30, 2025 /PRNewswire/ -- In a significant development in an ongoing legal dispute, the U.S. Patent and…

6 months ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a…

6 months ago

2025 Kia Telluride ranks number one in its segment in J.D. Power 2025 U.S. Initial Quality Study (IQS)

Kia’s Award-Winning Three-Row SUV Earns Top Spot in Upper Midsize SUV Segment2025 Telluride named the Upper Midsize SUV segment winner…

7 months ago